Loading…
3M entered into an agreement to sell substantially all of its drug delivery business to an affiliate of Altaris Capital Partners, retaining its transdermal drug delivery components business.
“3M recently announced that it has entered into an agreement to sell substantially all of its drug delivery business to an affiliate of Altaris Capital Partners, LLC.”adhesivesmag.com
Summarized from public sources; check the original articles before acting on it.